Torrent Pharmaceuticals Limited (TORNTPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has a cash flow conversion efficiency ratio of 0.123x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs10.38 Billion ≈ $112.26 Million USD) by net assets (Rs84.49 Billion ≈ $913.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Torrent Pharmaceuticals Limited for the company's overall valuation and market capitalisation.
Torrent Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how Torrent Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Torrent Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Explore TORNTPHARM operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yihai Kerry Arawana Holdings Co Ltd
SHE:300999
|
0.138x |
|
CLP HLDGS LTD ADR/1 HD 5
F:CLP1
|
N/A |
|
InterGlobe Aviation Limited
NSE:INDIGO
|
1.544x |
|
Henkel AG & Co. KGaA
XETRA:HEN
|
0.041x |
|
OMV Aktiengesellschaft
VI:OMV
|
0.036x |
|
Charter Communications Inc
NASDAQ:CHTR
|
0.204x |
|
Bayan Resources Tbk
JK:BYAN
|
0.092x |
|
Telia Company AB
ST:TELIA
|
0.136x |
Annual Cash Flow Conversion Efficiency for Torrent Pharmaceuticals Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of Torrent Pharmaceuticals Limited from 2005 to 2026. View TORNTPHARM stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs175.85 Billion ≈ $1.90 Billion |
Rs26.32 Billion ≈ $284.64 Million |
0.150x | -56.05% |
| 2025-03-31 | Rs75.91 Billion ≈ $820.94 Million |
Rs25.85 Billion ≈ $279.56 Million |
0.341x | -28.51% |
| 2024-03-31 | Rs68.56 Billion ≈ $741.47 Million |
Rs32.66 Billion ≈ $353.21 Million |
0.476x | +24.69% |
| 2023-03-31 | Rs61.98 Billion ≈ $670.29 Million |
Rs23.68 Billion ≈ $256.09 Million |
0.382x | +26.14% |
| 2022-03-31 | Rs59.53 Billion ≈ $643.79 Million |
Rs18.03 Billion ≈ $194.99 Million |
0.303x | -12.07% |
| 2021-03-31 | Rs58.37 Billion ≈ $631.27 Million |
Rs20.11 Billion ≈ $217.45 Million |
0.344x | +19.37% |
| 2020-03-31 | Rs48.23 Billion ≈ $521.61 Million |
Rs13.92 Billion ≈ $150.52 Million |
0.289x | -24.18% |
| 2019-03-31 | Rs47.24 Billion ≈ $510.92 Million |
Rs17.98 Billion ≈ $194.46 Million |
0.381x | +96.76% |
| 2018-03-31 | Rs46.23 Billion ≈ $499.93 Million |
Rs8.94 Billion ≈ $96.70 Million |
0.193x | -16.90% |
| 2017-03-31 | Rs43.51 Billion ≈ $470.50 Million |
Rs10.13 Billion ≈ $109.52 Million |
0.233x | -70.92% |
| 2016-03-31 | Rs33.89 Billion ≈ $366.56 Million |
Rs27.13 Billion ≈ $293.43 Million |
0.800x | +146.11% |
| 2015-03-31 | Rs24.91 Billion ≈ $269.39 Million |
Rs8.10 Billion ≈ $87.62 Million |
0.325x | +3.25% |
| 2014-03-31 | Rs19.03 Billion ≈ $205.78 Million |
Rs5.99 Billion ≈ $64.82 Million |
0.315x | +191.92% |
| 2013-03-31 | Rs14.22 Billion ≈ $153.82 Million |
Rs1.53 Billion ≈ $16.60 Million |
0.108x | -74.53% |
| 2012-03-31 | Rs11.97 Billion ≈ $129.49 Million |
Rs5.07 Billion ≈ $54.87 Million |
0.424x | +9.98% |
| 2011-03-31 | Rs10.24 Billion ≈ $110.74 Million |
Rs3.95 Billion ≈ $42.67 Million |
0.385x | +11.56% |
| 2010-03-31 | Rs8.31 Billion ≈ $89.87 Million |
Rs2.87 Billion ≈ $31.04 Million |
0.345x | -12.83% |
| 2009-03-31 | Rs6.51 Billion ≈ $70.39 Million |
Rs2.58 Billion ≈ $27.89 Million |
0.396x | -16.47% |
| 2008-03-31 | Rs5.10 Billion ≈ $55.11 Million |
Rs2.42 Billion ≈ $26.14 Million |
0.474x | +164.43% |
| 2007-03-31 | Rs4.10 Billion ≈ $44.37 Million |
Rs735.97 Million ≈ $7.96 Million |
0.179x | +81.59% |
| 2006-03-31 | Rs3.48 Billion ≈ $37.62 Million |
Rs343.63 Million ≈ $3.72 Million |
0.099x | +23.72% |
| 2005-03-31 | Rs3.16 Billion ≈ $34.12 Million |
Rs251.96 Million ≈ $2.72 Million |
0.080x | -- |
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-int… Read more